Home > > Asia And Global Pharmaceutical Contract Development and Manufacturing Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET 3.1. OVERVIEW 3.2. ASIA 3.2.1. ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE 3.2.2. ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER 3.2.3. ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY 3.2.3.1. CHINA 3.2.3.1.1. CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE 3.2.3.1.2. CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER 3.2.3.2. JAPAN 3.2.3.2.1. JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE 3.2.3.2.2. JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER 3.2.3.3. INDIA 3.2.3.3.1. INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE 3.2.3.3.2. INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER 3.2.3.4. ROAPAC 3.2.3.4.1. ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE 3.2.3.4.2. ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER CHAPTER 4: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE 4.1. OVERVIEW 4.2. PHARMACEUTICAL MANUFACTURING SERVICES 4.2.1. PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY REGION 4.2.1.1. NORTH AMERICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY 4.2.1.2. EUROPE PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY 4.2.1.3. ASIA PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY 4.3. BIOLOGICS MANUFACTURING SERVICES 4.3.1. BIOLOGICS MANUFACTURING SERVICES MARKET, BY REGION 4.3.1.1. NORTH AMERICA BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY 4.3.1.2. EUROPE BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY 4.3.1.3. ASIA BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY 4.4. DRUG DEVELOPMENT SERVICES 4.4.1. DRUG DEVELOPMENT SERVICES MARKET, BY REGION 4.4.1.1. NORTH AMERICA DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY 4.4.1.2. EUROPE DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY 4.4.1.3. ASIA DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY CHAPTER 5: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER 5.1. OVERVIEW 5.2. BIG PHARMA 5.2.1. BIG PHARMA MARKET, BY REGION 5.2.1.1. NORTH AMERICA BIG PHARMA MARKET, BY COUNTRY 5.2.1.2. EUROPE BIG PHARMA MARKET, BY COUNTRY 5.2.1.3. ASIA BIG PHARMA MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA BIG PHARMA MARKET, BY COUNTRY 5.3. SMALL & MID-SIZE PHARMA 5.3.1. SMALL & MID-SIZE PHARMA MARKET, BY REGION 5.3.1.1. NORTH AMERICA SMALL & MID-SIZE PHARMA MARKET, BY COUNTRY 5.3.1.2. EUROPE SMALL & MID-SIZE PHARMA MARKET, BY COUNTRY 5.3.1.3. ASIA SMALL & MID-SIZE PHARMA MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA SMALL & MID-SIZE PHARMA MARKET, BY COUNTRY 5.4. GENERIC PHARMACEUTICAL COMPANIES 5.4.1. GENERIC PHARMACEUTICAL COMPANIES MARKET, BY REGION 5.4.1.1. NORTH AMERICA GENERIC PHARMACEUTICAL COMPANIES MARKET, BY COUNTRY 5.4.1.2. EUROPE GENERIC PHARMACEUTICAL COMPANIES MARKET, BY COUNTRY 5.4.1.3. ASIA GENERIC PHARMACEUTICAL COMPANIES MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA GENERIC PHARMACEUTICAL COMPANIES MARKET, BY COUNTRY 5.5. OTHER END USERS 5.5.1. OTHER END USERS MARKET, BY REGION 5.5.1.1. NORTH AMERICA OTHER END USERS MARKET, BY COUNTRY 5.5.1.2. EUROPE OTHER END USERS MARKET, BY COUNTRY 5.5.1.3. ASIA OTHER END USERS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA OTHER END USERS MARKET, BY COUNTRY FIGURE 98. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 03. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 04. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($MILLION) TABLE 06. ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 07. ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) TABLE 09. CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 10. JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) TABLE 11. JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 12. INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) TABLE 13. INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 14. ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) TABLE 15. ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) TABLE 17. PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. DRUG DEVELOPMENT SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 33. BIG PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 34. NORTH AMERICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. EUROPE BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. ASIA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. MIDDLE EAST & AFRICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. SMALL & MID-SIZE PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 01. TOP INVESTMENT POCKETS: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 02. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 03. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($MILLION) FIGURE 04. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($MILLION) FIGURE 05. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($MILLION) FIGURE 06. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($MILLION) FIGURE 07. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 08. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 09. TOP INVESTMENT POCKETS: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 10. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 11. TOP INVESTMENT POCKETS: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 12. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 13. TOP INVESTMENT POCKETS: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 14. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 15. TOP INVESTMENT POCKETS: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 16. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 17. TOP INVESTMENT POCKETS: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 18. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 19. TOP INVESTMENT POCKETS: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 20. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 21. TOP INVESTMENT POCKETS: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 22. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 23. TOP INVESTMENT POCKETS: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 24. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 25. TOP INVESTMENT POCKETS: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 26. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 27. TOP INVESTMENT POCKETS: PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 28. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 29. TOP INVESTMENT POCKETS: NORTH AMERICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 30. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 31. TOP INVESTMENT POCKETS: EUROPE PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 32. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 33. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 34. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 35. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 36. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 37. TOP INVESTMENT POCKETS: BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 38. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 39. TOP INVESTMENT POCKETS: NORTH AMERICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 40. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 41. TOP INVESTMENT POCKETS: EUROPE BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 42. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 43. TOP INVESTMENT POCKETS: ASIA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 44. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 45. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 46. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 47. TOP INVESTMENT POCKETS: DRUG DEVELOPMENT SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 48. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: DRUG DEVELOPMENT SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 49. TOP INVESTMENT POCKETS: NORTH AMERICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 50. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 51. TOP INVESTMENT POCKETS: EUROPE DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 52. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 53. TOP INVESTMENT POCKETS: ASIA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 54. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 55. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 56. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 57. TOP INVESTMENT POCKETS: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 58. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 59. TOP INVESTMENT POCKETS: BIG PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 60. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BIG PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 61. TOP INVESTMENT POCKETS: NORTH AMERICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 62. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 63. TOP INVESTMENT POCKETS: EUROPE BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 64. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 65. TOP INVESTMENT POCKETS: ASIA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 66. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 67. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 68. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 69. TOP INVESTMENT POCKETS: SMALL & MID-SIZE PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 70. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: SMALL & MID-SIZE PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 71. TOP INVESTMENT POCKETS: NORTH AMERICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 72. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 73. TOP INVESTMENT POCKETS: EUROPE SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 74. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 75. TOP INVESTMENT POCKETS: ASIA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 76. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 77. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 78. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 79. TOP INVESTMENT POCKETS: GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 80. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 81. TOP INVESTMENT POCKETS: NORTH AMERICA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 82. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 83. TOP INVESTMENT POCKETS: EUROPE GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 84. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 85. TOP INVESTMENT POCKETS: ASIA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 86. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 87. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 88. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA GENERIC PHARMACEUTICAL COMPANIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 89. TOP INVESTMENT POCKETS: OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 90. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 91. TOP INVESTMENT POCKETS: NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 92. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 93. TOP INVESTMENT POCKETS: EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 94. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 95. TOP INVESTMENT POCKETS: ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 96. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 97. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 98. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES FIGURE 01. TOP INVESTMENT POCKETS: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 02. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 03. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($MILLION) FIGURE 04. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($MILLION) FIGURE 05. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($MILLION) FIGURE 06. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($MILLION) FIGURE 07. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 08. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 09. TOP INVESTMENT POCKETS: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 10. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 11. TOP INVESTMENT POCKETS: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 12. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: CHINA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 13. TOP INVESTMENT POCKETS: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 14. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 15. TOP INVESTMENT POCKETS: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 16. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: JAPAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 17. TOP INVESTMENT POCKETS: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 18. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 19. TOP INVESTMENT POCKETS: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 20. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: INDIA PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 21. TOP INVESTMENT POCKETS: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 22. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 23. TOP INVESTMENT POCKETS: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 24. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ROAPAC PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 25. TOP INVESTMENT POCKETS: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 26. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY SERVICE, 2023-2030, ($ MILLION) FIGURE 27. TOP INVESTMENT POCKETS: PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 28. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 29. TOP INVESTMENT POCKETS: NORTH AMERICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 30. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 31. TOP INVESTMENT POCKETS: EUROPE PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 32. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 33. TOP INVESTMENT POCKETS: ASIA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 34. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 35. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 36. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 37. TOP INVESTMENT POCKETS: BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 38. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 39. TOP INVESTMENT POCKETS: NORTH AMERICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 40. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 41. TOP INVESTMENT POCKETS: EUROPE BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 42. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 43. TOP INVESTMENT POCKETS: ASIA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 44. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 45. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 46. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA BIOLOGICS MANUFACTURING SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 47. TOP INVESTMENT POCKETS: DRUG DEVELOPMENT SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 48. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: DRUG DEVELOPMENT SERVICES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 49. TOP INVESTMENT POCKETS: NORTH AMERICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 50. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 51. TOP INVESTMENT POCKETS: EUROPE DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 52. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 53. TOP INVESTMENT POCKETS: ASIA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 54. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 55. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 56. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA DRUG DEVELOPMENT SERVICES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 57. TOP INVESTMENT POCKETS: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 58. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) FIGURE 59. TOP INVESTMENT POCKETS: BIG PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 60. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BIG PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 61. TOP INVESTMENT POCKETS: NORTH AMERICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 62. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 63. TOP INVESTMENT POCKETS: EUROPE BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 64. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 65. TOP INVESTMENT POCKETS: ASIA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 66. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 67. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 68. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA BIG PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 69. TOP INVESTMENT POCKETS: SMALL & MID-SIZE PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 70. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: SMALL & MID-SIZE PHARMA MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 71. TOP INVESTMENT POCKETS: NORTH AMERICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 72. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA SMALL & MID-SIZE PHARMA MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 73. TOP INVESTMENT POCKETS: EUROPE SMALL & MID-SIZE PHARMA MARKET VALUE,